Skip to Content

WATSON 240 0.5 (Lorazepam 0.5 mg)

Pill with imprint WATSON 240 0.5 is White, Round and has been identified as Lorazepam 0.5 mg. It is supplied by Watson Laboratories, Inc..

Lorazepam is used in the treatment of anxiety; insomnia; icu agitation; light anesthesia; nausea/vomiting and belongs to the drug classes benzodiazepine anticonvulsants, benzodiazepines, miscellaneous antiemetics. There is positive evidence of human fetal risk during pregnancy. Lorazepam 0.5 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).

Images for WATSON 240 0.5

Lorazepam 0.5 mg WATSON 240 0.5
Lorazepam 0.5 mg WATSON 240 0.5
Lorazepam 0.5 mg WATSON 240 0.5 Front
Lorazepam 0.5 mg WATSON 240 0.5 Back
Lorazepam 0.5 mg WATSON 240 0.5


WATSON 240 0.5
0.5 mg
6.00 mm
Prescription only
Drug Class:
Benzodiazepine anticonvulsants
Miscellaneous antiemetics
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
4 - Some potential for abuse
Labeler / Supplier:
Watson Laboratories, Inc.
Inactive Ingredients:

Note: Inactive ingredients may vary.

Labelers / Repackagers:

NDC CodeLabeler / Repackager
00591-0240 Watson Pharmaceuticals, Inc.
63739-0499 McKesson Packaging Services
66267-0133 Nucare Pharmaceuticals Inc. (repackager)
43063-0057 PDRX Pharmaceuticals Inc. (repackager)
55289-0402 PDRX Pharmaceuticals Inc. (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.